Urology · KIMS Secunderabad
Nocturia — Waking at Night to Urinate: Causes, Evaluation, and Treatment
Nocturia — waking from sleep to urinate one or more times per night — is one of the most common and most disruptive urological symptoms across all age groups. By the age of 60, approximately 60% of men and 50% of women wake at least once per night to urinate. By 70, the majority wake twice or more. Many people accept this as an inevitable part of ageing. It is not. Nocturia has identifiable causes, most of which are treatable, and untreated nocturia carries consequences that go well beyond a disturbed night: cumulative sleep deprivation, increased falls risk in elderly patients (the risk of hip fracture is significantly elevated in nocturia patients who fall during night-time toilet trips), daytime fatigue, reduced concentration, and significantly reduced quality of life.
The most important thing to understand about nocturia is that it is a symptom — not a diagnosis. Multiple different conditions cause nocturia through different mechanisms, and the treatment depends entirely on identifying which mechanism or combination of mechanisms is responsible in the individual patient. Giving all nocturia patients a bladder medication is as incorrect as giving all headache patients a single treatment — the cause determines the cure.
How much nocturia is normal ?
Waking once per night to urinate is generally considered the upper limit of normal in adults below 65. In the elderly (above 65), once per night is common and may not represent pathology. Waking twice or more per night is clinically significant at any age and warrants evaluation. The clinical threshold used in most guidelines is one or more voids per night — but the decision to investigate and treat should be guided by the impact on the individual: if a single nocturnal void is causing significant sleep disruption and daytime fatigue, it deserves the same attention as three voids per night in someone who sleeps through it.
Causes — the three mechanisms of nocturia
Nocturia results from one or more of three fundamental mechanisms: the bladder produces too much urine at night (nocturnal polyuria), the bladder cannot hold enough urine during the night (reduced nocturnal bladder capacity), or a combination of both. Understanding which mechanism is driving nocturia in each patient requires a frequency-volume chart — a 3-day diary of every void, its volume, and whether it occurred during the day or night.
1 — Nocturnal polyuria (NP): too much urine produced at night
Nocturnal polyuria is defined as the production of more than 33% of the 24-hour urine output during the night (in patients above 65, the threshold is 20 to 33%). It is the most common mechanism of nocturia in elderly patients. Causes: • Excessive evening fluid intake — the simplest and most common reversible cause. Drinking large volumes of fluid in the 2 to 3 hours before bed results in nocturnal diuresis. Includes alcohol and caffeinated beverages consumed after dinner. • Cardiac failure with peripheral oedema — fluid retained in dependent tissues (ankles, legs) during the day redistributes to the circulation when the patient lies down at night, is filtered by the kidneys, and is excreted as urine. Classic pattern: bilateral ankle swelling during the day, nocturia at night, improved with diuretics taken in the morning. A cardiological assessment is required. • Venous insufficiency — similar mechanism to cardiac failure. Leg oedema from venous insufficiency redistributes at night, causing nocturnal diuresis. • Hypertension treated with evening diuretics — diuretics taken late in the day drive nocturnal urine production. Timing the diuretic dose to morning or early afternoon resolves the problem. • Antidiuretic hormone (ADH/vasopressin) deficiency — the normal physiological mechanism that reduces overnight urine production (rising ADH at night) may be blunted with age or impaired in diabetes insipidus, causing nocturnal polyuria. Desmopressin (synthetic ADH) directly addresses this mechanism. • Diabetes mellitus — poorly controlled diabetes produces glucosuria and osmotic diuresis around the clock, including at night. • Obstructive sleep apnoea — the negative intrathoracic pressure generated during apnoeic episodes stretches the atria, releasing atrial natriuretic peptide (ANP), which stimulates renal sodium and water excretion. OSA is a commonly overlooked cause of nocturnal polyuria. Treatment of OSA with CPAP reliably reduces nocturia.
2 — Reduced nocturnal bladder capacity: the bladder cannot hold enough urine
• Overactive bladder (OAB) — detrusor overactivity reduces the bladder volume at which the urgency sensation triggers — the bladder effectively has a smaller functional capacity during the night. Nocturia from OAB is accompanied by urgency and daytime frequency. • Benign prostatic hyperplasia (BPH) — bladder outlet obstruction from an enlarged prostate causes the bladder wall to hypertrophy and develop secondary detrusor overactivity, reducing functional capacity. Nocturia is one of the most bothersome storage symptoms of BPH. Effective BPH treatment (HoLEP, TURP, or medical therapy) reduces nocturia. • Cystitis and bladder inflammation — urinary tract infection, radiation cystitis, and interstitial cystitis all reduce functional bladder capacity and cause nocturia alongside urgency and frequency. • Incomplete bladder emptying (high post-void residual) — if the bladder does not empty fully, the effective storage capacity for new urine is reduced, causing more frequent voids including at night.
3 — Global polyuria: too much urine produced all day and night
• Diabetes mellitus — osmotic diuresis from glucosuria causes polyuria throughout the 24 hours. • Diabetes insipidus — central (ADH deficiency) or nephrogenic (collecting duct insensitivity to ADH) causes very high urine volumes (more than 3 litres per day), including at night. • Primary polydipsia — excessive fluid intake (psychiatric or habitual) drives 24-hour polyuria. • Chronic kidney disease — impaired tubular concentrating ability causes dilute, high-volume urine throughout the day and night. • Hypercalcaemia and hypokakaemia — electrolyte disturbances can impair tubular function and cause polyuria.
The frequency-volume chart — the essential diagnostic tool
Before any nocturia investigation or treatment, a 3-day frequency-volume chart (FVC) is essential. The patient records every void — time, volume (measuring with a jug), and whether it felt urgent. This single test directs the entire diagnostic and treatment pathway.
What the frequency-volume chart identifies
The 3-day FVC is reviewed at the follow-up consultation at KIMS and used to identify which of the three mechanisms is responsible — and therefore which treatment pathway to follow:
24-hour urine volume — to detect global polyuria (more than 40 ml/kg/day).
Nocturnal urine volume as a proportion of 24-hour output — to detect nocturnal polyuria (more than 33% in adults below 65, 20 to 33% in those above 65).
Average and maximum daytime voided volume — quantifies functional bladder capacity. A reduced maximum volume points to reduced bladder capacity as the dominant mechanism.
The number and volume of nocturnal voids — quantifies severity and provides an objective baseline for monitoring treatment response.
At KIMS, the frequency-volume chart is provided to the patient at the first consultation and reviewed at the follow-up.
Treatment — matched to the mechanism
Once the dominant mechanism is identified from the frequency-volume chart and workup, treatment is targeted specifically at that mechanism. The cards below pair each clinical scenario with the standard KIMS management approach.
Nocturnal polyuria from evening fluid excess
Restrict fluids to 1.5–2L total daily; avoid fluid after 6pm; eliminate evening alcohol and caffeine.
Nocturnal polyuria from cardiac oedema
Morning diuretic; optimise cardiac failure management; compression stockings and leg elevation in the afternoon.
Nocturnal polyuria from ADH insufficiency (age-related or diabetes insipidus)
Desmopressin (nasal spray or oral tablet taken at bedtime). Reduces nocturnal urine production by 30–50%. Caution: hyponatraemia risk — sodium monitoring required, particularly in elderly patients.
Nocturnal polyuria from obstructive sleep apnoea
CPAP therapy — reliably reduces nocturia by treating the ANP-mediated nocturnal diuresis. Refer to sleep medicine for formal assessment (overnight oximetry, polysomnography).
OAB-driven reduced capacity
Bladder training · antimuscarinic (solifenacin, fesoterodine) · beta-3 agonist (mirabegron) · intradetrusor Botox for refractory cases.
BPH-driven reduced capacity
Alpha-blocker (tamsulosin, silodosin) · 5-alpha reductase inhibitor (finasteride, dutasteride) · HoLEP or TURP for definitive surgical treatment. HoLEP at KIMS — best long-term nocturia outcomes of any BPH procedure.
Evening diuretics causing nocturnal diuresis
Change diuretic timing to morning or early afternoon (in consultation with prescribing physician).
Diabetes mellitus (poorly controlled)
Optimise glucose control — HbA1c below 7%. Osmotic diuresis from glucosuria resolves with glycaemic control.
High post-void residual
Alpha-blocker for BPH · clean intermittent self-catheterisation (CISC) if obstruction cannot be corrected · surgical decompression.
Book a Nocturia Assessment at KIMS
Frequently Asked Questions — Nocturia
Once per night is the upper limit of normal in adults below 65 and is common in those above 65. However, 'common with age' and 'normal' are not the same thing — once-nightly nocturia that causes significant sleep disruption or daytime fatigue is worth investigating and treating regardless of age. Twice or more per night is clinically significant at any age and has identifiable, treatable causes in the majority of cases. The impact on quality of life — not the number alone — should guide the decision to seek assessment.
In men, benign prostatic hyperplasia (BPH) is the most common cause — accounting for the majority of nocturia presentations in men above 50. The enlarged prostate causes bladder outlet obstruction, which leads to secondary detrusor overactivity, reduced functional bladder capacity, and storage symptoms including nocturia. However, nocturnal polyuria — producing too much urine at night — is the most common mechanism of nocturia overall in both sexes across all age groups. In many men with BPH, both mechanisms are present simultaneously, which is why BPH treatment alone may not fully resolve nocturia if nocturnal polyuria is also contributing.
Yes — cardiac failure with peripheral oedema is a classic cause of nocturnal polyuria and nocturia. During the day, fluid accumulates in the dependent tissues (ankles, lower legs) because the failing heart cannot maintain adequate venous return. When the patient lies down at night, this peripheral oedema redistributes into the central circulation, is filtered by the kidneys, and excreted as urine — causing nocturnal polyuria and nocturia. The pattern is characteristic: bilateral ankle swelling during the day, two to three nocturnal voids, improved urinary frequency during the day. If a patient reports ankle swelling alongside nocturia, a cardiological assessment is essential before treating the nocturia in isolation.
Yes — and this is one of the most commonly missed connections in the management of nocturia. During obstructive sleep apnoea, the repetitive apnoeic episodes generate large negative intrathoracic pressure swings as the patient struggles to breathe against the closed airway. This stretches the cardiac atria, causing release of atrial natriuretic peptide (ANP) — a hormone that promotes renal sodium and water excretion. The result is nocturnal polyuria and nocturia. Studies show that treating OSA with CPAP reduces nocturnal voids by 50% or more in patients who have OSA-driven nocturia. Anyone with nocturia who also snores heavily, stops breathing during sleep (reported by a partner), or has daytime sleepiness should be screened for OSA.
Desmopressin (a synthetic analogue of antidiuretic hormone/vasopressin) directly reduces overnight urine production by increasing tubular water reabsorption. It is effective for nocturia driven by nocturnal polyuria from age-related ADH insufficiency or diabetes insipidus — reducing nocturnal voids by one to two times in many patients. The most important risk is hyponatraemia (low blood sodium) — desmopressin causes water retention and dilutes serum sodium. Serum sodium must be measured 3 to 7 days after starting desmopressin and monitored periodically. The risk is highest in elderly patients, those on diuretics, and those with a low baseline sodium. At KIMS, desmopressin for nocturia is prescribed with a sodium monitoring protocol built in.
The KIMS nocturia assessment includes: a 3-day frequency-volume chart (the single most informative investigation — reviewed at the follow-up appointment), morning urine dipstick and culture, fasting glucose and HbA1c, serum sodium, potassium, calcium, creatinine and eGFR, PSA (in men above 45 with obstructive symptoms), uroflowmetry and post-void residual (bladder ultrasound). A sleep apnoea screening questionnaire (Epworth Sleepiness Scale, STOP-BANG) is used to identify patients who should be referred for formal sleep assessment. Urodynamics is reserved for cases where OAB or neurogenic bladder is suspected.
Multiple age-related changes converge to increase nocturia prevalence with advancing age. The normal circadian pattern of ADH secretion — which reduces overnight urine production — becomes blunted with age, leading to more nocturnal urine production. Bladder capacity may reduce. BPH causes storage symptoms in many men. Cardiac and venous disease become more common, increasing peripheral oedema that redistributes at night. Sleep architecture changes — lighter sleep and more frequent spontaneous awakenings mean that the bladder threshold that wakes a person is reached more easily. Medications for hypertension, heart failure, and other conditions (particularly diuretics) affect urine production timing. The result is that nocturia becomes increasingly common with age — but the causes are identifiable and the symptoms are treatable in most patients.
KIMS Secunderabad — Dr. Neil Narendra Trivedi (MCh Urology KEM Hospital Mumbai, Member SIU), structured nocturia assessment including frequency-volume chart, 24-hour urine volume measurement, sleep apnoea screening, cardiac and metabolic evaluation, uroflowmetry, full BPH assessment and surgical treatment (HoLEP — no prostate size limit, lowest retreatment rate), OAB treatment including urodynamics and bladder rehabilitation. NABH and NABL accredited. Call 040-4488-5000.